Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated May 15, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q1 2026. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 35.7B USD
- Positions
- 77
- Share of the ten largest
- 34.9%
The ten largest positions Q1 2026
- Visa Inc. 5.4%▲ +58.8%
- Taiwan Semiconductor Manufacturing (ADR) 4.2%▼ −9.2%
- Charles Schwab Corporation 3.9%▲ +5.7%
- Walt Disney Company (The) 3.6%▲ +18.8%
- Fortive 3.5%▲ +16.9%
- Air Products 3.3%▼ −14.2%
- Mcdonalds Corp 3.2%▲ +0.2%
- Sherwin-Williams 2.8%▼ −1.9%
- Tesla, Inc. 2.6%▲ +46.7%
- Apple Inc. 2.6%new
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q1 2026
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc | 2.5% | 11,842,434 | 879.4M USD | −17.7% reduced | Q2 2019 28 quarters |
| Adaptive Biotechnologies Cor | 1.2% | 29,993,708 | 416.3M USD | unchanged | Q2 2019 28 quarters |
| FTV Fortive | 3.5% | 22,479,388 | 1.2B USD | +16.9% increased | Q3 2019 27 quarters |
| Api Group Corp | 0.7% | 5,837,000 | 236.5M USD | −49.4% reduced | Q2 2020 24 quarters |
| Pharvaris N V | 0.3% | 3,653,310 | 103.2M USD | unchanged | Q1 2021 21 quarters |
| Biomarin Pharmaceutical Inc | 1.1% | 7,062,077 | 398.9M USD | +17.0% increased | Q4 2021 18 quarters |
| Roivant Sciences Ltd | 0.5% | 6,652,448 | 184.3M USD | +3.2% increased | Q4 2021 18 quarters |
| Pepgen Inc | < 0.1% | 3,482,434 | 6.2M USD | unchanged | Q2 2022 16 quarters |
| Trevi Therapeutics Inc | 0.1% | 3,198,644 | 38.2M USD | unchanged | Q3 2022 15 quarters |
| CSX CSX Corporation | 2.1% | 18,678,052 | 766.7M USD | +35.2% increased | Q4 2022 14 quarters |
| Newamsterdam Pharma Company | 0.4% | 4,203,567 | 134.6M USD | unchanged | Q4 2022 14 quarters |
| TMUS T-Mobile US | 1.7% | 2,967,374 | 623.2M USD | −21.0% reduced | Q4 2023 10 quarters |
| Regal Rexnord Corporation | 1.6% | 3,142,851 | 588.5M USD | −2.5% reduced | Q4 2023 10 quarters |
| HCA HCA Healthcare | 1.4% | 1,075,133 | 508.8M USD | +7.6% increased | Q4 2023 10 quarters |
| CPT Camden Property Trust | 1.3% | 4,715,394 | 460.5M USD | −1.0% reduced | Q1 2024 9 quarters |
| Oric Pharmaceuticals Inc | 0.2% | 5,824,533 | 73.8M USD | −11.4% reduced | Q1 2024 9 quarters |
| Standard Biotools Inc | 0.2% | 58,651,170 | 53.9M USD | unchanged | Q1 2024 9 quarters |
| SHW Sherwin-Williams | 2.8% | 3,112,767 | 997.8M USD | −1.9% reduced | Q2 2024 8 quarters |
| CVNA Carvana | 2.4% | 2,780,035 | 874.0M USD | +161.9% increased | Q2 2024 8 quarters |
| JPM JPMorgan Chase | 2.2% | 2,704,018 | 795.4M USD | +41.9% increased | Q2 2024 8 quarters |
| Inhibrx Biosciences Inc | 0.3% | 1,437,705 | 96.7M USD | unchanged | Q2 2024 8 quarters |
| V Visa Inc. | 5.4% | 6,328,185 | 1.9B USD | +58.8% increased | Q3 2024 7 quarters |
| SCHW Charles Schwab Corporation | 3.9% | 14,664,954 | 1.4B USD | +5.7% increased | Q3 2024 7 quarters |
| Ginkgo Bioworks Holdings Inc | < 0.1% | 3,577,128 | 21.9M USD | unchanged | Q3 2024 7 quarters |
| TSM Taiwan Semiconductor Manufacturing (ADR) | 4.2% | 4,465,127 | 1.5B USD | −9.2% reduced | Q4 2024 6 quarters |
| GM General Motors | 1.9% | 9,176,943 | 683.7M USD | +34.8% increased | Q4 2024 6 quarters |
| BA Boeing | 1.8% | 3,196,041 | 636.1M USD | −19.2% reduced | Q4 2024 6 quarters |
| Mcdonalds Corp | 3.2% | 3,625,029 | 1.1B USD | +0.2% increased | Q1 2025 5 quarters |
| TSLA Tesla, Inc. | 2.6% | 2,493,561 | 927.0M USD | +46.7% increased | Q1 2025 5 quarters |
| SE Sea Limited (ADR) | 1.1% | 4,737,196 | 392.3M USD | +29.0% increased | Q1 2025 5 quarters |
| COF Capital One | 0.8% | 1,612,374 | 294.1M USD | −45.4% reduced | Q1 2025 5 quarters |
| Amer Sports Inc | 0.7% | 7,270,476 | 239.3M USD | +51.0% increased | Q1 2025 5 quarters |
| Tic Solutions Inc | 0.7% | 35,824,562 | 235.7M USD | +4.3% increased | Q1 2025 5 quarters |
| Sionna Therapeutics Inc | 0.4% | 3,195,181 | 128.1M USD | unchanged | Q1 2025 5 quarters |
| DIS Walt Disney Company (The) | 3.6% | 13,298,462 | 1.3B USD | +18.8% increased | Q2 2025 4 quarters |
| APD Air Products | 3.3% | 4,104,095 | 1.2B USD | −14.2% reduced | Q2 2025 4 quarters |
| PNC PNC Financial Services | 1.8% | 3,027,092 | 629.9M USD | −58.5% reduced | Q2 2025 4 quarters |
| JCI Johnson Controls | 1.6% | 4,419,923 | 578.8M USD | −25.3% reduced | Q2 2025 4 quarters |
| Ralliant Corp | 0.2% | 2,134,899 | 88.8M USD | −32.5% reduced | Q2 2025 4 quarters |
| MSFT Microsoft | 2.4% | 2,309,446 | 854.9M USD | −28.2% reduced | Q3 2025 3 quarters |
| MAA Mid-America Apartment Communities | 1.6% | 4,798,404 | 586.0M USD | +23.7% increased | Q3 2025 3 quarters |
| Celestica Inc | 1.3% | 1,654,989 | 466.2M USD | −2.6% reduced | Q3 2025 3 quarters |
| AON Aon plc | 1.0% | 1,087,114 | 350.9M USD | +38.7% increased | Q3 2025 3 quarters |
| Oruka Therapeutics Inc | 0.4% | 2,666,690 | 130.8M USD | unchanged | Q3 2025 3 quarters |
| TMO Thermo Fisher Scientific | 2.3% | 1,668,025 | 819.9M USD | +110.3% increased | Q4 2025 2 quarters |
| ICE Intercontinental Exchange | 2.1% | 4,836,896 | 760.7M USD | +0.7% increased | Q4 2025 2 quarters |
| LII Lennox International | 2.0% | 1,572,419 | 729.8M USD | +153.1% increased | Q4 2025 2 quarters |
| GOOGL Alphabet Inc. (Class A) | 1.9% | 2,395,865 | 689.0M USD | −10.1% reduced | Q4 2025 2 quarters |
| Medline Inc | 1.4% | 11,433,992 | 508.8M USD | +64.3% increased | Q4 2025 2 quarters |
| CB Chubb Limited | 1.2% | 1,295,011 | 422.1M USD | +27.7% increased | Q4 2025 2 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 longest-held of 77 positions.
Breakdown by sector
- Financials 20.4%
- Industrials 13.0%
- Consumer Discretionary 10.5%
- Communication Services 9.9%
- Technology 9.6%
- Materials 6.1%
- Health Care 5.0%
- Real Estate 2.9%
- not in our coverage 22.6%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors